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Abstract
Background: In-vitro expansion of functional beta cells from adult human islets is an attractive approach for generating an
abundant source of cells for beta-cell replacement therapy of diabetes. Using genetic cell-lineage tracing we have recently
shown that beta cells cultured from adult human islets undergo rapid dedifferentiation and proliferate for up to 16
population doublings. These cells have raised interest as potential candidates for redifferentiation into functional insulin-
producing cells. Previous work has associated dedifferentiation of cultured epithelial cells with epithelial-mesenchymal
transition (EMT), and suggested that EMT generates cells with stem cell properties. Here we investigated the occurrence of
EMT in these cultures and assessed their stem cell potential.
Methodology/Principal Findings: Using cell-lineage tracing we provide direct evidence for occurrence of EMT in cells
originating from beta cells in cultures of adult human islet cells. These cells express multiple mesenchymal markers, as well
as markers associated with mesenchymal stem cells (MSC). However, we do not find evidence for the ability of such cells,
nor of cells in these cultures derived from a non-beta-cell origin, to significantly differentiate into mesodermal cell types.
Conclusions/Significance: These findings constitute the first demonstration based on genetic lineage-tracing of EMT in
cultured adult primary human cells, and show that EMT does not induce multipotency in cells derived from human beta
cells.
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Introduction
In-vitro expansion of functional beta cells from the limited
number of donated adult human pancreata is an attractive
approach for generating an abundant source of cells for beta-cell
replacement therapy of diabetes. Despite evidence supporting the
replicative capacity of both rodent and human beta cells in vivo [1–
4], attempts at expanding human islet cells in vitro resulted in
limited replication and loss of beta-cell phenotype [5–7]. To
monitor the fate of cultured human beta cells we developed a
lineage-tracing approach based on a Cre-loxP-mediated DNA
recombination system delivered by lentivirus vectors [8]. Using
this system .50% of the insulin-positive cells present in isolated
human islets could be specifically labeled with enhanced green
fluorescent protein (eGFP). The labeled beta cells were shown to
undergo rapid dedifferentiation and proliferate readily for up to 16
population doublings. The percent of eGFP
+ cells remained stable
during the entire expansion period, suggesting a comparable
replication rate of eGFP
+ and eGFP
2 cells [8]. In contrast to
human beta cells, labeling of mouse beta cells by transgenic
methods [9–12], as well as by our lentivirus method [8], showed
that mouse beta cells did not significantly proliferate under these
culture conditions.
Dedifferentiation of epithelial cells has been associated with
epithelial-mesenchymal transition (EMT) in cultured thyroid cells
[13]. EMT plays a key role in morphogenic changes during
embryonic development and in tumor metastasis (see ref. [14] for a
recent review), however its role in cell dedifferentiation remains
unclear. Furthermore, previous work has suggested that EMT
generates cells with stem cell properties [15]. Gershengorn et al.
postulated that beta cells in cultures of adult human islets
underwent EMT upon entrance into the cell cycle [16], however,
in the absence of cell lineage-tracing there was no direct evidence
for the origin of mesenchymal cells from beta cells in these
cultures. Subsequent work from this group abandoned the EMT
hypothesis and suggested instead that cells expanded in human
islet cultures, termed human Islet Progenitor Cells (hIPC), were
derived from rare mesenchymal stem cells (MSC) normally present
in the islets. hIPCs expanded in vitro were shown to express MSC
markers, and a fraction of them differentiated in vitro into
mesodermal cell types, such as adipocytes and osteocytes [17].
The presence of MSC in some human islet preparations was
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in islets in vivo has not been confirmed, and their occurrence in
preparations of isolated islets may result from contaminating
pancreatic exocrine and duct tissue [19].
Our lineage tracing approach allows direct evaluation as to the
occurrence of EMT in cultured human beta cells. Here we report
that cells originating from beta cells undergo EMT in cultures of
adult human islet cells and express multiple mesenchymal markers,
as well as markers associated with MSC. However, we do not find
evidence for the ability of such cells, nor of other cells in these
cultures expressing MSC markers, which are derived from a non-
beta-cell origin, to significantly differentiate into mesodermal cell
types. These findings constitute the first demonstration based on
genetic lineage-tracing of EMT in cultured adult primary human
cells, and show that EMT does not induce multipotency in cells
derived from human beta cells.
Materials and Methods
Ethics statement
This study was conducted according to the principles expressed
in the Declaration of Helsinki. The Institutional Review Boards of
the medical centers, which provided human islets (members of the
Islet Cell Resource Consortium) and bone marrow, each provided
approval for the collection of samples and subsequent analysis. All
donors provided written informed consent for the collection of all
samples and subsequent analysis.
Vector construction and production
The reporter lentiviral vector was modified from pTrip CMV-
loxP-DsRed2-loxP-eGFP DeltaU3 [8] as follows. The DsRed2
sequence was removed and replaced by the reading frame A
Gateway cassette (Gateway Conversion Kit, Invitrogen), upstream
of a stop linker composed of 6 stop codons placed as pairs in the 3
reading frames, resulting in pTrip–loxP-Gateway-STOP-loxP-
eGFP DeltaU3 destination vector. The Neomycin resistance gene
was amplified by PCR from pcDNA3 vector using the forward
primer 59CACCATGATTGAACAAGATGGA39 and reverse
primer 59GAAGAACTCGTCAAGAAGGCGA39,a n dt h er e s u l t -
ing PCR product was cloned into the pENTR/D/TOPO plasmid
(Invitrogen) to generate a Neomycin entry clone. Both entry clone
and destination vector were used for in-vitro recombination mediated
by LR clonase II (Invitrogen), resulting in a new reporter lentiviral
vector,pTrip–loxP-NEO-STOP-loxP-eGFPDeltaU3.Atamoxifen-
inducible form of Cre (Cre-ERT2) was cloned downstream of the
405-bp fragment of the rat insulin promoter (RIP 405). Briefly, LR
clonase II recombination was performed using pTrip RIP405 rfa-
Gateway DeltaU3 destination vector [8] and pENTR/D/TOPO–
Cre-ERT2 entry clone. The Cre-ERT2 fragment was amplified by
PCR from a plasmid kindly provided by Guilan Vodjdani using the
forward primer 59CACCGGTACCCTCGAGATCGAT39 and
reverse primer 59TCAAGCTGTGGCAGGGAAACC39, and the
resulting PCR product was cloned into the pENTR/D/TOPO
plasmid to generate the Cre-ERT2 entry clone. Virus particles were
produced in 293T cells following vector cotransfection with the
pCMVdR8.91 and pMD2.G plasmids. The culture medium was
harvested 36–48 h later.
Cell culture and infection
Human islets were received in our laboratory 3.161.4 days
following isolation. Islet purity was determined by staining with
dithizone. Islets from individual donors were dissociated into single
cells and cultured as described [20]. Following 1 day in culture
cells were washed with PBS and infected with a 1:1 mixture of the
2 viruses at MOI 3:1 in CMRL containing 8 mg/ml polybrene
overnight. The medium was replaced in the morning, and 4-
hydroxy-tamoxifen (Sigma-Aldrich, St.Louis, MO) was added to a
final concentration of 1 mM in the evening. Following overnight
incubation the medium was changed to regular growth medium.
Human bone marrow cells were obtained from adult donors at
Lanadio Hospital under approved protocols. Human bone
marrow derived MSC (BM-MSC) were isolated and cultured as
described [21].
Cell sorting and flow cytometry
Labeled cells were sorted using a FACS Aria cell sorter (Becton
Dickinson, San Jose, CA) with a fluorescein isothiocyanate (FITC)
filter (530/30 nm) for eGFP. Dead cells stained with 7-amino
actinomycin D (7-AAD, Invitrogen) were excluded using a PerCP-
Cy5.5 filter (695/40 nm).
RNA analysis
Total RNA was isolated using Trizol (Sigma-Aldrich, St.Louis,
MO) and treated with DNA-free (Ambion, Redwood, TX) to
remove genomic DNA. cDNA was prepared using High Capacity
Figure 1. Inducible labeling of human islet cells. A, Schematic
representation of the two lentivirus vectors. B, Labeling efficiency and
leakiness. Adult human islet cells from 5 donors were infected one day
after plating with the reporter virus alone, or with both viruses, and
cultured overnight in the absence or presence of tamoxifen. Five days
later 10
4 cells from each donor were analyzed by flow cytometry for
eGFP expression. Data are mean6SD (n=5).
doi:10.1371/journal.pone.0006417.g001
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quantitation (qRT-PCR) was performed using the following Assay-
on-Demand kits (Applied Biosystems, Foster City, CA): insulin, Hs
00355773 m1; E-Cadherin, Hs 01013953 m1; smooth muscle
actin, Hs 00909449 m1; CD73, Hs 00159686 m1; CD90, Hs
00174816 m1; CD105, Hs 00164438 m1; N-Cadherin, Hs
00169953 m1; vimentin, Hs 00185584 m1; RPLP0, Hs
99999902 m1. All reactions were done in triplicates. The results
were normalized to human large ribosomal protein P0 cDNA
(RPLP0).
Immunofluorescence
Cells grown on sterilized coverslips were washed with PBS and
fixed with 4% paraformaldehyde (PFA) for 10 min at room
temperature. Slides were permeabilized for 10 min with 0.25%
NP40. Cells were blocked for 40 min with 5% fetal goat serum,
1% bovine serum albumin and 0.2% saponin and incubated
overnight at 4uC with the primary antibodies diluted in blocking
solution. Cells were then washed and incubated for 40 min with
the secondary antibodies. Images were taken using a Zeiss LTM
200 Apotome or a Leica SP-5 confocal microscope. Expression of
eGFP was detected using mouse anti-GFP (Chemicon, 1:500) or
rabbit anti-GFP (Invitrogen, 1:1000). Other primary antibodies
used: mouse anti-human CD90 (BD Pharmingen, 1:100), mouse
anti-human CD105 (BD Pharmingen, 1:100), mouse anti-smooth
muscle actin (Progen, 1:250), rabbit anti-N-Cadherin (Abcam,
1:200), mouse anti-vimentin (Calbiochem, 1:50) and goat anti-fatty
acid binding protein 4 (FABP4) (R&D Systems, 1:100). Secondary
antibodies used: Alexa 488 or Alexa 546 anti-mouse IgG, anti-
rabbit IgG, or anti-goat IgG (all Invitrogen, 1:500). DNA was
stained with DAPI (Sigma-Aldrich, St.Louis, MO).
Induction of MSC differentiation into adipocytes and
osteocytes
The differentiation experiments were preformed with 3 different
kits (Lonza, Walkersville, MD; StemCell Technologies, Vancou-
ver; R&D Systems, Minneapolis, MN). Briefly, BM-MSC and
expanded islet cells were seeded on glass slides at densities
indicated by the manufacturers. Thereafter cultures were treated
according to the manufactures protocols. To identify lipid vacuoles
cells were fixed for 20 min in 4% PFA and stained for 30 min in
0.3% Oil Red O (Sigma-Aldrich, St.Louis, MO). Calcium
deposition was visualized by fixing cells for 20 min in 4% PFA
followed by staining with 0.5% Alizarin Red (Sigma-Aldrich,
St.Louis, MO) for 5 min. Following staining with dyes slides were
thoroughly washed with water, and nuclei were counterstained
using haematoxylin (Pioneer, Essex).
Statistical analysis
Significance was determined using a two tailed t-test or x
2-test.
To approach a normal distribution of the quantitative RT-PCR
data, a logarithmic transformation was preformed.
Results
To allow improved labeling of human beta cells for lineage
tracing we generated a RIP-Cre/ER lentivirus, in which
expression of Cre recombinase is inducible by tamoxifen. In
Figure 2. Changes in expression of epithelial and mesenchymal genes in human islet cells during the first 3 weeks in culture. RNA
was extracted from cells at the indicated passage number (each passage is equivalent to one week) and analyzed by qRT-PCR. A, analysis of epithelial
genes. B, analysis of mesenchymal genes. Data represent relative quantification (RQ) (compared to passage 0) and are mean6SE (n=6 donors).
*p,0.05; ** p,0.005; ***p,0.0005 (compared to passage 0).
doi:10.1371/journal.pone.0006417.g002
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structure CMVp-loxP-NEO-STOP-loxP-eGFP (Fig. 1). This
vector lacks the DsRed2 gene that was present in the previous
version, following our finding that DsRed2 expression interfered
with sorting of eGFP
+ cells by FACS. Beta cells infected by both
constructs are expected to express Cre protein, however Cre will
translocate into the nucleus only upon addition of tamoxifen,
leading to removal of the floxed DNA fragment in the reporter
construct and activation of eGFP expression. This system provides
a labeling efficiency comparable to that of the original labeling
system [8], averaging 20.3% of the total islet cells (Fig. 1). (It
should be noted that the term ‘‘islet cells’’ refers to the isolated islet
preparations, which contain about 20% contaminating pancreatic
non-islet cells). Its leakiness in the absence of tamoxifen is relatively
low, averaging 1.7% of the total islet cells (Fig. 1). It should be
noted that this limited leakiness nevertheless represents specific
labeling of beta cells, and does not constitute a drawback in the
context of this study. Given the islet purity (81.669.4%, based on
dithizone staining), and the average of 55% insulin-positive cells
among human islet cells [22], ,44.9% of the cells could be
expected to be insulin-positive at the time of islet isolation. Thus,
labeling of 20.3% of the total islet cells represents an efficiency of
beta-cell labeling of at least 45.2%, which is comparable to the
57.568.9% reported for the original labeling system [8]. Given
that dithizone staining is inaccurate, the actual labeling efficiency
could deviate somewhat from the one calculated based on
dithizone staining.
Human islets isolated from both male and female donors (age
44.9612.8; BMI 27.665.8) were dissociated into single cells and
cultured as described [8]. One day after infection with the two
lentiviruses constituting the labeling system cultures were treated
with tamoxifen overnight to label the beta cells. They were then
expanded and split 1:2 once a week. Analysis of gene expression in
the cultured cells revealed a rapid loss of beta-cell and epithelial
phenotypes, as manifested by a large decrease in the levels of
insulin and E-cadherin mRNAs (Fig. 2A). In parallel, a
pronounced increase in levels of transcripts encoding mesenchy-
mal and MSC markers was detected. These included the
mesenchymal markers smooth-muscle actin (SMA), N-cadherin,
and vimentin, and the MSC markers CD73, CD90, and CD105
(Fig. 2B). These results were reproducible in cells derived from 6
donors.
To evaluate the changes in cells derived from beta cells, eGFP
+
cells were fractionated by FACS and analyzed for gene expression.
This fractionation resulted in .4X enrichment of eGFP
+ cells, to
.82% of the sorted cell population. In the eGFP
2 population
generated by cell sorting the percent of residual eGFP
+ cells was
,7.9%. In addition, this population also contained unlabeled cells
derived from beta cells. Thus, while the 2 populations were
enriched, they were not pure. Nevertheless, mRNA analyses
revealed significant differences in gene expression between the 2
populations. At passage 2 insulin mRNA levels in the sorted
eGFP
+ cells were 84-fold lower, compared with the islet
population at passage 0, however they were 36.268.9-fold higher,
compared with those in eGFP
2 cells (n=3 donors, p=0.002)
(Fig. 3A). Similarly, E-cadherin mRNA levels in the sorted eGFP
+
cells at passage 2 were 5-fold lower, compared with the islet
population at passage 0, and 4.560.8-fold higher, compared with
Figure 3. Changes in expression of epithelial and mesenchymal genes in sorted eGFP
+ and eGFP
2 cells following 2 weeks in culture.
RNA was extracted from cells at the indicated passage number and analyzed by qRT-PCR. A, analysis of epithelial genes. B, analysis of mesenchymal
genes. Data represent relative quantification (RQ) (compared to passage 0) and are mean6SE (n=3 donors). *p,0.05; ** p,0.005.
doi:10.1371/journal.pone.0006417.g003
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2 cells (Fig. 3A, p=0.005). In contrast, the
mesenchymal and MSC markers analyzed were greatly elevated
in both eGFP
+ and eGFP
2 cells, and no significant differences
were noted between the 2 populations (Fig. 3B). Similar differences
were found in cells from 3 donors sorted at passage 3 (data not
shown).
These analyses suggested that expression of the mesenchymal
and MSC markers was greatly elevated in cells derived from beta
cells. To directly verify this possibility, labeled cells at passage 4
were stained with antibodies to eGFP and 5 mesenchymal and
MSC markers (Fig. 4). Scoring of .400 cells stained for each
antigen in cells derived from each of 3 donors revealed that
94.169.3% and 93.664.5% of eGFP
+ cells were positive for
CD90 and CD105, respectively. Similarly, 99.760.5% and
95.965.5% of eGFP
+ cells were positive for N-cadherin and
vimentin, respectively. In contrast, in freshly isolated islets, and in
islet cells during the first 2 days of culture, only very rare C-
peptide
+ cells were positive for these markers (data not shown).
The mesenchymal and MSC markers were also highly abundant
in eGFP
2 cells (Fig. 4), confirming the lack of significant
differences in transcript levels for these markers between sorted
eGFP
+ and eGFP
2 cells (Fig. 3B). Taken together, these findings
directly demonstrate the activation of mesenchymal and MSC
markers in cells derived from beta cells, thus supporting the
occurrence of EMT in these cells.
To investigate whether the expanded islet cells, which acquired
MSC markers, also developed multipotency, they were treated with
inducers of adipocyte and osteocyte differentiation. As seen in
Fig. 5A, these inducers resulted in efficient differentiation of adult
human BM-MSC into adipocytes and osteocytes, as detected by
staining with Oil Red O and Alizarin Red, respectively. In contrast,
only very rare cells stained with these dyes were detected in cells
expanded from adult human islets. To specifically assay the capacity
to differentiate into adipocytes in cells derived from beta cells,
eGFP
+ cells were stained with antibodies for the adipocyte marker
fatty acid binding protein 4 (FABP4). As seen in Fig. 5B and 5C,
73.1613.8% of BM-MSC were stained for this marker following
induction of differentiation into adipocytes. In contrast, only
5.562.9% of all cells expanded from adult human islet cells and
induced to differentiate into adipocytes at passages 3–8 were
Figure 4. Expression of mesenchymal genes in eGFP
+ cells. Cells at passage 4 were stained with antibodies to eGFP and the indicated
mesenchymal marker. Nuclei were stained blue with DAPI. Bar=20 mm. The percentages indicate the fraction of cells positive for each mesenchymal
marker among eGFP
+ cells (green digits) and among all the cells (white digits). Data are mean6SD of .400 cells scored from each donor (n=3
donors).
doi:10.1371/journal.pone.0006417.g004
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derived from 6 donors). Among all cells positive for FABP4, only
1.4% were eGFP
+ cells (representing ,0.08% of the total
population). When scoring specifically eGFP
+ cells (a total of 2378
cells counted from 5 donors), 1.961.6% were found to be positive
for FABP4. Similar results were obtained with 2 additional kits of
reagents for induction of MSC differentiation into adipocytes (data
not shown). These results demonstrate that cells derived from beta
cells, which undergo EMT and acquire MSC markers, are not bona
fide MSC, as judged by their inability to efficiently differentiate into
mesodermal cell types. In addition, the adipocyte and osteocyte
differentiation capacity of eGFP
2 cells in these cultures, the
majority of which also express MSC markers and are derived from
unknown non-beta-cell sources in the islet preparation, is also quite
limited, compared with that of BM-MSC.
Discussion
These results provide direct evidence for occurrence of EMT in
adult human beta cells propagated in culture. This possibility was
first suggested by Gershengorn et al. [16], however this group did
not present unequivocal data in its support, and eventually backed
up from it [17]. Given that nearly all the cells in cultures of human
islet cells express mesenchymal markers, and on average about
40% of these cells are derived from beta cells [8], our data suggest
that about 40% of the cells expressing mesenchymal markers in
these cultures are derived by EMT from beta cells. EMT has been
documented during embryonic development and in pathological
conditions, such as tumor progression and fibrosis. However, to
our knowledge this is the first demonstration based on genetic
lineage-tracing of EMT in cultured adult primary human cells.
Figure 5. Differentiation of cells expanded from human islet cells into adipocytes and osteocytes. A, Islet cells at the indicated passage
number were incubated in Lonza induction medium and stained with Oil Red O for adipocytes and Alizarin Red for osteocytes. Human BM-MSC
served as positive control. Bar=100 mm. B, Islet cells at passage 5 and BM-MSC were incubated in Lonza adipogenesis induction medium and stained
with antibodies to eGFP and FABP4. Nuclei were stained blue with DAPI. Bar=30 mm. The eGFP
+ cells shown do not stain for FABP4. The single
FABP4
+ cell shown is not eGFP
+. C, Quantitation of the staining in B, based on counting .500 cells in cultures derived from each donor. Data
represent percent of FABP4
+ among eGFP
+ cells (green bars) and among all the cells (black bars) and are mean6SD (n=6 donors for islet cells and 2
donors for BM-MSC). p=4.18E-14.
doi:10.1371/journal.pone.0006417.g005
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dissociation from the normal epithelial structure, resulting in
altered cell-cell and cell-matrix contacts. In intact islets cultured on
adherent surfaces this dissociation occurs gradually, and activation
of mesenchymal marker expression is observed within several
weeks in cells migrating out of the islet cell cluster [16]. In our islet
cell expansion protocol, which involves trypsinization of isolated
islets into a single-cell suspension prior to plating, this is a rapid
process, leading to appearance of mesenchymal markers in the
vast majority of the cells within several days [8,20]. The loss of
normal cell-cell and cell-matrix contacts likely leads to intracellular
signaling events resulting in profound changes in gene expression,
including loss of expression of differentiated beta-cell markers and
activation of mesenchymal and MSC markers. It is not known
whether EMT is required for induction of cell replication. The
switch from E-cadherin to N-cadherin, which is a hallmark of
EMT, has been shown to be associated with activation of the
WNT pathway and regulation of cell proliferation and differen-
tiation in multiple systems [23–25]. We have shown that the
NOTCH pathway, which is also turned on during EMT [26], is
activated in cultured human beta cells, and its activation is
required for induction of cell proliferation [27]. However, it is
possible that the state of responsiveness to replication cues from
culture medium components is induced in these cells in part
independently of EMT, by other changes in gene expression
triggered by cell culture.
Despite studies on cell cycle regulation in beta cells (see refs. 28
and 29 for reviews), our understanding of the relations between
beta-cell replication and expression of differentiated functions
remains limited. It is unknown whether differentiated beta cells in
human pancreas in vivo must undergo temporary dedifferentiation/
EMT before entering cell cycle. Nevertheless, it appears that
induction of significant beta-cell replication in vitro requires cell
delamination out of the normal epithelial structure, a process that
results in EMT, as revealed here by cell lineage tracing. In the
context of ex vivo expansion of human islet beta cells for eventual
use in cell therapy of diabetes, this dedifferentiation may be an
unavoidable price to pay for increasing cell mass. We hypothesize
that the dedifferentiated beta cells may retain epigenetic
modifications in loci important for the beta-cell phenotype,
making these loci relatively accessible to transcription, compared
with cells from other tissues. However, transcription may be
prevented by loss of expression of transcription activators, and
upregulation of transcription repressors, resulting from cell
delamination and replication. Once the normal repertoire of
transcription activation and repression factors is restored by
shifting the culture to appropriate differentiation conditions, the
permissive chromatin structure may facilitate re-establishment of
the beta-cell phenotype. This hypothesis is supported by our
findings of partial restoration of beta-cell gene expression in vitro,
obtained using relatively simple manipulations [20,27], and is
currently a central focus of research in our laboratory.
In addition to mesenchymal markers, culturing of human islet
cells induced expression of several markers which are character-
istic of the MSC phenotype (CD73, CD90, and CD105) in the
majority of the cells. However, our results show that on average
only 5.5% of the expanded islet cells at different passages can be
viewed as bona fide MSC, as judged by their ability to differentiate
into adipocytes or osteocytes. Moreover, very few of these cells
(1.4%) were derived from beta cells. These findings were
reproducible with 3 different commercial differentiation kits.
These results differ from previous work, which reported consid-
erable differentiation into mesodermal cell types of MSC-like cells
derived from islet cells expanded in vitro [16,18]. However, these
results are difficult to compare to ours, since these groups did not
provide quantitative data. In addition, it is possible that the culture
method employed in these studies, which plated intact islets, as
opposed to the initial islet dissociation employed in our protocol,
results in preferential expansion of a different cell population. This
possibility is supported by differences observed between cells
expanded by the two protocols in doubling time (about 7 days in
our protocol, compared with 2.5 days in the Gershengorn
protocol) and overall expansion rate (,10
5-fold in our protocol,
compared with 10
12-fold in the Gershengorn protocol). Our
findings indicate that EMT does not induce multipotency in the
dedifferentiated beta cells, suggesting that they retain a restricted
differentiation potential and may be amenable to redifferentiation
into functional beta cells.
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